Aktuellt
SENASTE
Redeye provides an update following Acconeer’s Q3 2024 results and updated go-to-market strategy. Net sales were below expectations while cost control remains solid, albeit partly driven by increased capitalised R&D y/y. Thus, EBITDA was better than anticipated. Inventory continues to come down, and the A2 will be finalised in 2025, with Redeye expecting low volumes in H2 2025 with ramp-up during 2026. Redeye reduces its estimates and fair value range.
LÄS MER
